Trials / Recruiting
RecruitingNCT06483698
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery: A Retrospective Multi-center Study (EarlyLC-RW)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- —
Summary
The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of early-stage lung cancer patients who have received surgery using the real-world data. The main questions it aims to answer are: * What is the best surgical strategy for patients with early-stage lung cancer? * What are the risk factors for early-stage lung cancer? Participants will receive surgery and the study will analyze the real-world data.
Detailed description
This observational study aims to comprehensively evaluate the effectiveness and long-term clinical outcomes of surgical interventions in early-stage lung cancer patients, utilizing real-world data. Central to this investigation are two key questions: * What is the optimal surgical approach for managing early-stage lung cancer? * What are the primary risk factors associated with the development of early-stage lung cancer? Participants will undergo surgical procedures, and through rigorous analysis of real-world data, this study endeavors to provide nuanced insights into these fundamental queries, fostering advancements in clinical decision-making and patient management strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sublobar resection | Sublobar resection is a series of surgical approaches for lung cancer. |
| OTHER | Lobectomy | Lobectomy is the surgical approach for lung cancer. |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2026-03-01
- Completion
- 2034-12-01
- First posted
- 2024-07-03
- Last updated
- 2025-08-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06483698. Inclusion in this directory is not an endorsement.